MedTrace Logo

Flaxseed Intervention Study to Assess Sex Hormone Levels Among Post-Menopausal Women

NCT02501031 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2018-01-12

No results posted yet for this study

Summary

The purpose of this study is to understand whether consuming flaxseed for approximately 50 days may beneficially affect the level of certain hormones in the blood thought to be involved in the development of breast cancer. This study will address the first steps toward the development of possible breast cancer prevention strategies. Differences in hormone levels (from blood samples) will be compared between two groups of women - those in the group assigned to eating ground flaxseed daily and those in the control group (with no change in diet).

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Ground flaxseed

2 tablespoons of ground flaxseed taken daily for approximately 50 days.

Sponsors & Collaborators

  • Canadian Breast Cancer Foundation, Ontario Region (funder)

    collaborator UNKNOWN

  • University of Toronto

    collaborator OTHER

  • York University, Institute for Social Research

    collaborator UNKNOWN

  • Mount Sinai Services

    collaborator UNKNOWN

  • Roswell Park Cancer Institute

    collaborator OTHER

  • Cancer Care Ontario

    lead OTHER

Principal Investigators

  • Michelle Cotterchio, PhD · Cancer Care Ontario and Dalla Lana School of Public Health, University of Toronto

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
57 Years
Max Age
64 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-06-30
Completion
2018-01-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02501031 on ClinicalTrials.gov